Adverse events, including voluntary psychiatric admission, suicide attempt, serious violent incident, voluntary admission to a general medical ward, overdose of medication or painkillers, were highest among the combined group compared to the monotherapies.
Over half of the sample attained opioids through their own prescription, and 47.2% of patients with co-occurring sedative use disorder attained sedatives by prescription.
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Researchers investigated subgroup responses to long-acting injectable medications haloperidol decanoate and paliperidone palmitate.
For patients with schizophrenia or schizoaffective disorder, younger age was significantly associated with an increased rate of readmission.
Emotional stability assessed in late adolescence is inversely associated with serious mental illness.
The burden of illness associated with bipolar disorder warrants early preemption.
Irritability may have wide-ranging impacts on symptomatic, functional, and social elements of quality of life.
Benefits of NMDA receptor agonists in patients with schizophrenia include improvements with memory and reading.
Study provides further evidence for the effects of cognitive enhancement intervention on brain functional connectivity and cognitive performance in patients with schizophrenia.